INOpulse

COMBINATION_PRODUCT2 trials

Sponsors

Bellerophon Pulse Technologies, Bellerophon

Conditions

COVID-19CoronavirusCoronavirus InfectionPulmonary FibrosisPulmonary Hypertension

Phase 3

A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19

TerminatedNCT04421508

Bellerophon Pulse TechnologiesCoronavirus, Coronavirus Infection, COVID-19

Start: 2020-07-12End: 2021-01-22Updated: 2023-02-21

Unknown Phase

Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

BellerophonPulmonary Fibrosis, Pulmonary Hypertension

Updated: 2023-02-21

Related Papers

May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?

Antioxidants2020-10-1014 citations